ESTRO 2024 - Abstract Book

S1721

Clinical - Lung

ESTRO 2024

6. De Baère T, Aupérin A, Deschamps F, et al. Radiofrequency ablation is a valid treatment option for lung metastases: Experience in 566 patients with 1037 metastases. Ann Oncol. 2015;26(5):987-991. doi:10.1093/annonc/mdv037

7. Pennathur A, Abbas G, Qureshi I, et al. Radiofrequency Ablation for the Treatment of Pulmonary Metastases. Ann Thorac Surg. 2009;87(4):1030-1039. doi:10.1016/j.athoracsur.2008.12.061

8. Chua TC, Sarkar A, Saxena A, Glenn D, Zhao J, Morris DL. Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients. Ann Oncol. 2010;21(10):2017-2022. doi:10.1093/annonc/mdq098

9. Akhan O, Guler E, Akinci D, Ciftci T, Kose IC. Radiofrequency ablation for lung tumors: outcomes, effects on survival, and prognostic factors. Diagnostic Interv Radiol. 2015;22(1):65-71. doi:10.5152/dir.2015.14378

10. Fanucchi O, Ambrogi MC, Aprile V, et al. Long-term results of percutaneous radiofrequency ablation of pulmonary metastases: a single institution experience †. Interact Cardiovasc Thorac Surg. 2016;23(1):57 -64. doi:10.1093/icvts/ivw089

11. Gillams A, Khan Z, Osborn P, Lees W. Survival after radiofrequency ablation in 122 patients with inoperable colorectal lung metastases. Cardiovasc Intervent Radiol. 2013;36(3):724-730. doi:10.1007/s00270-012-0500-3

12. Okunieff P, Petersen AL, Philip A, et al. Stereotactic Body Radiation Therapy (SBRT) for lung metastases. Acta Oncol (Madr). 2006;45(7):808-817. doi:10.1080/02841860600908954

13. Yoon SM, Choi EK, Lee SW, et al. Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors. Acta Oncol (Madr). 2006;45(8):1108-1114. doi:10.1080/02841860600812685 14. Takahashi W, Yamashita H, Niibe Y, Shiraishi K, Hayakawa K, Nakagawa K. Stereotactic Body Radiotherapy for Metastatic Lung Cancer as Oligo-Recurrence: An Analysis of 42 Cases. Pulm Med. 2012;2012:1-5. doi:10.1155/2012/454107

15. Rusthoven KE, Kavanagh BD, Burri SH, et al. Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases. J Clin Oncol. 2009;27(10):1579-1584. doi:10.1200/JCO.2008.19.6386

16. Dhakal S, Corbin KS, Milano MT, et al. Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: Excellent local lesion control and improved patient survival. Int J Radiat Oncol Biol Phys. 2012;82(2):940 945. doi:10.1016/j.ijrobp.2010.11.052

17. Norihisa Y, Nagata Y, Takayama K, et al. Stereotactic Body Radiotherapy for Oligometastatic Lung Tumors. Int J Radiat Oncol. 2008;72(2):398-403. doi:10.1016/j.ijrobp.2008.01.002

18. Takeda A, Kunieda E, Ohashi T, Aoki Y, Koike N, Takeda T. Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer. Radiother Oncol. 2011;101:255-259. doi:10.1016/j.radonc.2011.05.033

19. Ricardi U, Filippi AR, Guarneri A, et al. Stereotactic body radiation therapy for lung metastases. Lung Cancer. 2011;75:77-81. doi:10.1016/j.lungcan.2011.04.021